Results of Automated Retinal Image Analysis for Detection of Diabetic Retinopathy from the Nakuru Study, Kenya. by Hansen, Morten B et al.
Hansen, MB; Abrmoff, MD; Folk, JC; Mathenge, W; Bastawrous,
A; Peto, T (2015) Results of Automated Retinal Image Analysis for
Detection of Diabetic Retinopathy from the Nakuru Study, Kenya.
PLoS One, 10 (10). e0139148. ISSN 1932-6203 DOI: 10.1371/jour-
nal.pone.0139148
Downloaded from: http://researchonline.lshtm.ac.uk/2319312/
DOI: 10.1371/journal.pone.0139148
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
RESEARCH ARTICLE
Results of Automated Retinal Image Analysis
for Detection of Diabetic Retinopathy from
the Nakuru Study, Kenya
Morten B. Hansen1,2☯*, Michael D. Abràmoff3☯, James C. Folk3☯, Wanjiku Mathenge4☯,
Andrew Bastawrous5☯, Tunde Peto1☯
1 NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of
Ophtalmology, London, United Kingdom, 2 Research Unit of Ophthalmology, University of Southern
Denmark, Odense, Denmark, 3 Department of Ophthalmology and Visual Sciences, University of Iowa
Hospital and Clinics, Iowa City, IA, 52242, United States of America, 4 Rwanda International Institute of
Ophthalmology, P.O. Box 312, Kigali, Rwanda, 5 International Centre for Eye Health, Department of Clinical
Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine
(LSHTM), London, United Kingdom
☯ These authors contributed equally to this work.
*morten.hansen@moorfields.nhs.uk
Abstract
Objective
Digital retinal imaging is an established method of screening for diabetic retinopathy (DR). It
has been established that currently about 1% of the world’s blind or visually impaired is due
to DR. However, the increasing prevalence of diabetes mellitus and DR is creating an
increased workload on those with expertise in grading retinal images. Safe and reliable
automated analysis of retinal images may support screening services worldwide. This study
aimed to compare the Iowa Detection Program (IDP) ability to detect diabetic eye diseases
(DED) to human grading carried out at Moorfields Reading Centre on the population of
Nakuru Study from Kenya.
Participants
Retinal images were taken from participants of the Nakuru Eye Disease Study in Kenya in
2007/08 (n = 4,381 participants [NW6 Topcon Digital Retinal Camera]).
Methods
First, human grading was performed for the presence or absence of DR, and for those with
DR this was sub-divided in to referable or non-referable DR. The automated IDP software
was deployed to identify those with DR and also to categorize the severity of DR.
Main OutcomeMeasures
The primary outcomes were sensitivity, specificity, and positive and negative predictive
value of IDP versus the human grader as reference standard.
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Results
Altogether 3,460 participants were included. 113 had DED, giving a prevalence of 3.3% (95%
CI, 2.7–3.9%). Sensitivity of the IDP to detect DED as by the human grading was 91.0% (95%
CI, 88.0–93.4%). The IDP ability to detect DED gave an AUC of 0.878 (95%CI 0.850–0.905).
It showed a negative predictive value of 98%. The IDPmissed no vision threatening retinopa-
thy in any patients and none of the false negative cases met criteria for treatment.
Conclusions
In this epidemiological sample, the IDP’s grading was comparable to that of human grad-
ers’. It therefore might be feasible to consider inclusion into usual epidemiological grading.
Introduction
Regular screening for diabetic retinopathy (DR) for at risk populations has been shown to be
an effective public health intervention for reducing the burden of disease in people living with
diabetes mellitus (DM), as DR is still one of the leading causes of visual impairment in industri-
alised countries. [1, 2] The latest global estimates show that there are 285 million people with
visual impairment, of whom 39 million are blind, with DR contributing to 1% of both to blind-
ness and visual impairment. [3] The low-income countries in Asia and Africa have both the
highest prevalence of DM and the highest expected rise in diseased population[4], but these
resource-poor communities lack infrastructure to implement organised DR screening pro-
grams (DRSP) where regular eye exams [5, 6] can minimise the risk of visual loss. For example
with only 2.7 ophthalmologists per million people in Sub-Saharan Africa, recommending the
addition of DRSP in the format it is currently delivered in more developed countries is
extremely challenging. [7, 8] Even in developed countries, such as the US, less than 60% of the
23 million people with DM had an eye examination in 2010. [7, 9] On the contrary, in the UK,
where the DRSP is publicly funded, nearly 80% of DM patients are screened annually, [5], and
as a result of this, DR is no longer the leading cause of blindness in the working age-group. [6]
Potentially, algorithms performing automated analysis of retinal images may address the need
for more affordable DRSP in certain settings. The Iowa Detection Program (IDP) was originally
designed to meet the rising demand for DRSP [10, 11]. IDP evaluates digital retinal images in an
automated fashion for the presence of moderate or more severe DR as well as diabetic macular
edema (DME) [10]. The IDP has been validated in independent cohorts of people with DM,
using internationally recognized DR grading standards [9, 12] and was reported to have diagnos-
tic accuracy comparable to that of fellowship-trained retinal specialists’. [10, 11]However, the
performance of IDP is yet to be evaluated on populations from Sub-Saharan Africa, especially in
the context of a population-based study where majority of the subjects are without DM.
The aim of this study is to determine the sensitivity, specificity, positive and negative predic-
tive value of IDP in detecting Diabetic Eye Disease (DED) and non-DED in the population
based Nakuru Study from Kenya. Human grading for DR used in this study was that carried
out in the Moorfields Reading Centre, London, UK.
Methods
Subject recruitment and imaging
Images and clinical data of participants of the Nakuru Eye Study, Kenya, were used for the
automated image analysis via the IDP software. The Nakuru Eye Study started in 2007/08
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where a total of 4,381 participants underwent complete ophthalmic examination, and in 3460
subjects, fundus imaging was performed and subsequently graded for DR. [13]
In summary, for fundus photography participants were dilated with Mydriacyl drops
(Alcon1) and retinal photographs were obtained using a Topcon1NW6S Non-Mydriatic Ret-
inal Camera. Two fields were imaged, one centred on the disc, one on the fovea. [13] All fundus
photographs were graded by human graders at Moorfields Eye Hospitals Reading Centre, UK.
[14] The grading protocol was as follows:
The grading protocol and ICDR reference standard
The human graders were masked to the patient’s status to having or not having DM. Table 1
Shows details of the grading scheme for human graders, in short, no retinopathy, mild, moder-
ate and severe non-proliferative DR (NPDR) and proliferative DR (PDR) characteristics were
determined by identifying individual lesions in the retina and the macular region. These lesions
were microaneurysm, haemorrhages, exudates, characteristics of clinically significant macular
edema (CSME) without being able to determine thickness due to lack of stereo imaging, cotton
wool spots (CWS), intraretinal microvascular abnormalities (IRMA) and new vessels on the
disc or elsewhere. In addition vascular abnormalities resembling new vessels characteristic of
DR were graded as referable retinopathy as well.
Iowa Diabetic Retinopathy (IDP) detection software
The details of the Iowa Detection Program (IDP) algorithm have been published in previous
papers. [9–11] IDP examines and analyses every pixel in an image to detect microaneurysms,
haemorrhages, exudates and cotton wool spots and has the ability to detect retinal neovascular-
ization. It combines image quality with its detection of lesions and makes a numerical output
between 0 and 1, called the dr-index. The closer the number to 1 the more likely that the
patient has DED, or that the image was ungradable. Both of these categories (DED and
Table 1. Grading protocol ICDR and ETDRS Severity Levels.
Measure Score Observable Findings
ICDR severity level
No apparent retinopathy 0 No abnormalities (Level 10 ETDRS)
Mild non-proliferative diabetic
retinopathy
1 Microaneurysm(s) only (Level 20 ETDRS)
Moderate non-proliferative
diabetic retinopathy
2 More than just microaneurysm(s) but less than severe non-
proliferative diabetic retinopathy (Level 35, 43, 47 ETDRS)
Severe non-proliferative
diabetic retinopathy
3 Any of the following: > 20 intra-retinal haemorrhages in each of 4
quadrants, deﬁnite venous beading in 2 quadrants, prominent
intra-retinal microvascular abnormalities in 1 quadrant, or no
signs of proliferative retinopathy. (Level 53 ETDRS: 4-2-1 rule)
Proliferative diabetic
retinopathy
4 One or more of the following: neovascularization and/or vitreous
or preretinal haemorrhages. (Levels 61, 65, 71, 75, 81, 85
ETDRS)
Macular oedema severity level
No macular oedema 0 No exudates and no apparent thickening within 1 disc diameter
from fovea
Macular oedema 1 Exudates or apparent thickening within 1 disc diameter from
fovea
Abbreviations: ETDRS, Early Treatment Diabetic Retinopathy study; ICDR, International Clinical Diabetic
Retinopathy
doi:10.1371/journal.pone.0139148.t001
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ungradable) then is required to be regarded by a human grader. The dr-index is compared to
the so-called set-point to give the final result of the analysis. The lower the set-point of the IDP,
the higher the sensitivity, with increases the likelihood of false positives (overcalls), and in turn
lowers specificity. Based on previous work[9, 11], 0.04 as a setpoint was found to be ideal to
strike a balance between sensitivity and specificity as at this level a sensitivity of 91.6% was
established. [11]
Methods of comparing human grading to IDP output
In order to be able to compare human grading output to DED output of IDP, the human grad-
ing had to be re-categorized as following: no-DED includes none/mild DR with no macular
oedema (denoted with 0); while DED includes levels of DR that are either currently sight
threatening (severe NPDR and above) or that has a higher chance of developing into sight
threatening disease within a year, such as moderate NPDR. In summary, the algorithm is set to
detect moderate to severe non-proliferative DR (NPDR), proliferative DR (PDR), or Diabetic
Macular Edema (DME), denoted as 1 for statistical purposes.
The IDP processed all available images. Once IDP results were locked using the predefined
set-point the human grading results were re-coded to reflect the IDP’s outcome as above, so
statistical analysis and like-for-like comparison could be made. Once the grading results were
brought into a comparable outcome, we reviewed the results and statistical analysis took place.
As mentioned the IDP categorises results as DED (moderate NPDR or above) present or
absent. Ungradeable images also obtain the value of 1, meaning DED due to the fact that these
images require human grading intervention, therefore for fair comparison, the image sets were
also compared including the ungradables.
Primary outcome measure
The primary outcomes were sensitivity, specificity, positive and negative predictive value of
IDP versus the human grading.
Statistical analysis
Statistical analysis was performed using SPSS, version 22.0.0.0 (IBM Corporation, Worldwide).
Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) of IDP
compared to the reference standard of human grading were calculated.
Two methods were used to calculate these values. First we used the IDP’s output of DED
and ungradeable/missing images were classified as a positive outcome and compared to the
same setting for the human grading. Second method we used only results from gradable images
to be analysed, both by the IDP and by the human grading for comparison.
Ethics approval
The Nakuru Eye study was granted ethical approval for their work granted by the London
School of Hygiene & Tropical Medicine, the Kenya Medical Research Institute (KEMRI) Ethi-
cal Committee and African Medical and Research Foundation (AMREF). Informed consent
was obtained from the participating subjects. [13]
Results
All available baseline images’ from the Nakuru study (6788 fundus photos of 3,460 partici-
pants) were graded both by human graders and IDP. Altogether, 132 eyes could not be
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photographed at all, and these were therefore not available for grading and subsequent statisti-
cal analysis.
Of the 3,460 participants, the human graders determined that 113 subjects had DED, giving
a prevalence of 3.3% (95% CI, 2.7–3.9%). There were 56 cases with moderate NPDR, 20 with
severe NPDR and 37 cases with PDR. In the Nakuru study altogether 6.5% of patients had dia-
betes, giving a 50.8% prevalence of DR in this cohort. [14]
Of the 3,460 participants, there were 91 true positive DED, 900 false positive DED, 2093
true negative DED and 22 false negative DED results. In 334 cases both the IDP and human
graded the image to be ungradable and therefor as a positive outcome. In 20 cases the human
graded the images as ungradable were the IDP analysed the images as sufficient for grading but
with no-DED.
First we analysed the total agreement between IDP and human grading including ungrad-
able results. Sensitivity of the IDP to the RC was 91.0% (95% CI, 88.0–93.4%), and specificity
was 69.9% (95% CI, 68.3–71.6%). The PPV was 32.1% (95% CI, 29.6–34.7%), whereas the NPV
was 98.0% (95% CI, 97.4–98.6%). (Table 2)
The IDP ability to detect DED gave in Fig 1 an AUC of 0.878 (95% CI 0.850–0.905) using
maximum likelihood estimation. [15]
Table 2. Results—Comparison of the grading of DED from the IDP and the Reading Centre.
Reading Centre
DED No-DED Ungradable
DED 91 900 0 991
IDP No-DED 22 2093 20 2135
Ungradable 0 0 334 334
113 2993 354 3460
doi:10.1371/journal.pone.0139148.t002
Fig 1. –The ROC.
doi:10.1371/journal.pone.0139148.g001
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Then we analysed the results without the ungradable images. We used the 91 true positive,
900 false positive, 2093 true negative and 22 false negative. The sensitivity was 80.5% (95% CI,
72.0–87.4%) and the specificity was 69.9% (95% CI, 68.3–71.6%). The PPV was 9.2% (95% CI,
7.5–11.2%) whereas the NPV was 99.0% (95% CI, 98.4–99.4%). (Table 2)
Of the 22 false negative cases (42 originally but 20 cases due to ungradable images), the
human graders classified five cases as PDR, two as severe NPDR, and 15 as moderate NPDR. A
retinal specialist, TP, reviewed these images a second time. The five cases read as PDR are
shown in Fig 2. Review by the retinal specialist found none to have DR, but all were vascular
abnormalities on the optic disc resembling PDR. Of the 2 cases graded as severe NPDR, both
were confirmed to have haemorrhages and vascular abnormalities as IRMA, while of the 15
cases of moderate NPDR per the RC, three cases were re-adjudicated as mild DR while 12
remained at moderate level. The 12 cases of moderate NPDR were confirmed to be accurate
with five showing only haemorrhages, three with IRMA and six cases showing a combination
of small haemorrhages, IRMA and CWS.
Table 3 shows the results re-calculated once the adjudication results were taken into
account. The modified sensitivity was 92.6% (95% CI, 89.7–94.7%), specificity 70.0% (95% CI,
68.3–71.6%), PPV 32.1% (95% CI, 29.6–34.7%) and NPV was 98.4% (95% CI, 97.8–98.9%).
Again after adjudication we performed analysis without the ungradable participants. This
analysis resulted in 91 true positive, 1234 false positive, 2121 true negative and 14 false nega-
tive. This meaning a sensitivity of 86.7% (95% CI, 78.6–92.5%), and the specificity was 70.0%
(95% CI, 68.3–71.7%). The PPV was 9.2% (95% CI, 7.5–11.2%) and the NPV was 99.3% (95%
CI, 98.9–99.6%).
Discussion
Overall, using automated image analysis software designed to detect sight threatening DR or
ungradable images on a population based sample at Nakuru district of Kenya, sensitivity of
91% and specificity of 69.9% were achieved with excellent NPV value of over 99%. No vision
threatening DR was missed in any patients. None of the false negative cases were found to have
vision-threatening DED by the human graders or met criteria for treatment. Delayed treatment
could have resulted from these missed cases; it would have been unlikely to lead to visual loss
and high-risk PDR within the recommended year of follow-up. [16]
This is the first time IDP has been used on an epidemiologic population sample from Africa,
i.e. not a set of people previously diagnosed with diabetes. With dark fundi in Sub-Saharan
populations there has been concern that this would lead to underestimation of DED by the
algorithms because lesions might have lower contrast with the retinal background. Our analysis
did not show any such underestimation, and results were comparable to earlier studies in pre-
dominantly white / Caucasian populations. [9] The IDP performed well and it showed good
results in differentiating participants into having no DED and having DED as a primary popu-
lation screening tool and achieved this within the similar timeframe of one minute per eye as
previously documented. [9] With DM becoming a major public health issue worldwide and a
69% rise estimated in the number of adults with DM in low-income countries [17], the need
for cost-effective DRSP is essential. This opens up the opportunity for population based screen-
ing programs all over the world speed up the disease detection process from image acquisition
to diagnosis and potentially reporting back to the outcome for timely treatment to be given. By
reliably identifying patients who are in need of further image analysis by human graders and
who potentially require treatment for DR conserves resources to those truly needing it. This
could be of value in low-income countries where ophthalmic image grading is regularly carried
out by the small number of ophthalmologists who are already overstretched coping with the
Automated Detection of Diabetic Retinopathy from the Nakuru Study
PLOS ONE | DOI:10.1371/journal.pone.0139148 October 1, 2015 6 / 9
Fig 2. –Five false negative cases.
doi:10.1371/journal.pone.0139148.g002
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demand. [18] Software that automatically detects sight threatening DR and ungradeable images
in at risk patients could be part of the solution to that. As if IDP can cut down on the number
of images to be seen by a human grading (in many cases an ophthalmologist) by over 60% as it
did in this study, it would reduce the burden on health systems.
Even though the IDP today delivers good results there are ways to improve. The IDP focuses
on detecting microaneurysms, haemorrhages, and exudates. Better detection of subtle changes
such as IRMA or beading and CWS may improve on the detection level between DED and
non-DED. This should be a focus point for future improvements to the algorithm.
At the moment the software only focuses on DR and no other eye diseases such as Age-
Related Macular Degeneration (AMD) and glaucoma are covered and no other major blinding
diseases are classified as abnormal by the software. For a complete clinical evaluation, the
patients’ retinal images still need to be seen by trained graders or ophthalmologist. Combining
software that screens for both DR, AMD and glaucoma would be the ideal solution for auto-
mated image analysis to lower the burden on healthcare worldwide. This should be an aim for
the future.
In conclusion, IDP performed well in detecting and differentiating between participants
with or without sight threatening DED and identified those with too poor quality images
appropriately. The IDP showed its ability to cut down on the images needed to be seen by a
grader by over 60%, provided only the device’s positive DED outputs were to be reviewed by a
human grader. Further improvements are required to enable automated image analysis for all
common diseases so large scale epidemiological studies, such as the Nakuru Eye Study, can be
safely graded with minimal human intervention.
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